Star Bulk Carriers Corp. Announcement Offering Price Range for the Equity Offering in Greece

IMPORTANT NOTICE – DISCLAIMER

Not for release or distribution or publication in whole or in part, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa. These materials do not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan or the Republic of South Africa.

The securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act“), and may not be offered or sold in the United States or to U.S. persons absent such registration, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No offering of securities is being made in the United States or to U.S. persons.

ATHENS, Greece, Sept. 08, 2026 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company”) (Nasdaq: SBLK), an international maritime shipping company based in the Marshall Islands specializing in the transportation of dry bulk commodities, today announced the offering price range (the “Offering Price Range”) for its offering in Greece of up to 4,400,000 new common registered voting shares of the Company, par value $0.01 each (the “New Shares” and such offering, the “Offering”).

The range for the offering price of the New Shares is €23.00 to €25.50 (in U.S. dollar is $26.75 – $29.66(1)). The final offering price of the New Shares in the Offering will be determined within the Offering Price Range, and will be published in accordance with the applicable legal and regulatory requirements upon completion of the Offering.

The New Shares have not been, and will not be, registered under the U.S. federal securities laws or the securities laws of any other jurisdiction, and the New Shares may not be offered or sold in the United States or to U.S. persons unless the New Shares are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. The New Shares are being offered and sold to non-U.S. persons outside the United States in offshore transactions in reliance on Regulation S under the Securities Act.

Tuesday, September 8, 2026

Star Bulk Carriers Corp.

Important Notice – Disclaimer

This announcement includes “forward-looking statements,” with respect to our expectations or beliefs concerning future events. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “projects,” “likely,” “would,” “will,” “could,” “should,” “may,” “forecasts,” “potential,” “continue,” “possible” and similar expressions or phrases may identify forward-looking statements.

All forward-looking statements involve risks and uncertainties. The occurrence of the events described depends on many factors, some or all of which are not predictable or within our control. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to, market conditions, disruptions to the mechanics required to operate cross-border trading, disruptions to trading on Euronext Athens, and other technical impediments to the commencement of trading. All future written and verbal forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We undertake no obligation, and specifically decline any obligation, except as required by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

______________________

1 The range for the offering price for the New Shares has been converted into U.S. dollars based on the Euro/U.S. dollar (EUR/USD) exchange rate as of September 7, 2026 (€1 =1.1631 USD). (Source: Bloomberg – “BGN”, at Greek market close).

Contacts

Company: Investor Relations / Financial Media:
Simos Spyrou, Christos Begleris Nicolas Bornozis
Co ‐ Chief Financial Officers President
Star Bulk Carriers Corp. Capital Link, Inc.
c/o Star Bulk Management Inc. 230 Park Avenue, Suite 1540
40 Ag. Konstantinou Av. New York, NY 10169
Maroussi 15124 Tel. (212) 661‐7566
Athens, Greece E‐mail: [email protected]
Email: [email protected] www.capitallink.com
www.starbulk.com  



Universal Electronics and Eneco Partner to Launch the Next-Generation Smart Thermostat, Enabling Richer Customer Engagement for Utilities

Universal Electronics and Eneco Partner to Launch the Next-Generation Smart Thermostat, Enabling Richer Customer Engagement for Utilities

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–
Universal Electronics Inc. (UEI), a global leader in smart home control and sensing solutions, proudly announces the launch of the TIDE™ Touch and TIDE™ Bridge products for Eneco, an international energy company operating in the Netherlands, Belgium and Germany, as part of a smart thermostat solution for the utilities market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908312501/en/

Universal Electronics and Eneco have partnered to launch the TIDE Touch, a next-generation smart thermostat. The device features built-in temperature, humidity, and proximity sensors that optimize energy use and home comfort.

Universal Electronics and Eneco have partnered to launch the TIDE Touch, a next-generation smart thermostat. The device features built-in temperature, humidity, and proximity sensors that optimize energy use and home comfort.

TIDE Touch and TIDE Bridge are part of UEI’s award-winning TIDE Family of thermostat designs, known for intuitive interfaces, robust connectivity, and energy-saving intelligence. Optimized in collaboration with Eneco, the solution was refined through a year of user trials and consumer feedback across the Netherlands, including pilot installations in households that helped refine product features, installation experience and the onboarding journey through the Eneco-branded Installation Assistant powered by UEI’s Nevo Assistant.

TIDE Touch & TIDE Bridge: Key Features and Benefits

  • Comprehensive Sensing: Built-in temperature, humidity, and proximity sensors optimize energy use and comfort.
  • Flexible Installation and Guided Onboarding: Wall-mounted or stand-alone, with a DIY-friendly setup using the Eneco app and the built-in UEI Installation Assistant.
  • Advanced Connectivity: Wi-Fi and Zigbee integration enable seamless connection with smart home devices for a wide range of new use cases, from precise heating control, multi-point sensing and automated energy-saving actions.
  • OpenTherm & On/Off Compatibility: Works with a wide range of boilers and heat pumps, including advanced control protocols.
  • Cloud Platform and API Integration: Secure connection to Eneco’s platform, with APIs that allow utilities to integrate onboarding and mobile control directly into their own apps, supported by the TIDE Developer Portal and local integration support.
  • Privacy by Design: GDPR-compliant, ensuring user data is protected by default.

“We are thrilled to introduce our TIDE thermostat solution with Eneco, building on our award-winning TIDE Family and the voices of real users,” said Randy van Wort, Sales Manager for Smart Home at Universal Electronics BV. “This collaboration enables us to deliver a user-centric thermostat solution that is easy for customers to install and for utilities to integrate, operate, and support.”

Eneco’s Business Owner, Energy Insights & Advice Services, Maties van Voorthuizen added, “With TIDE Touch, TIDE Bridge, and the supporting platform from UEI, we can offer our customers a future-ready solution that supports sustainable living and makes energy management effortless. The extensive user trials and guided installation approach ensure the solution is practical and reliable for everyday use, enabling smarter, more efficient energy management for our customers.”

The UEI TIDE Smart Thermostat solution is expected to be deployed in the Netherlands throughout Eneco’s customer footprint starting in Q3 2026.

Universal Electronics Inc. (NASDAQ: UEIC) is the global leader in universal wireless control solutions for the home. The company brings to life millions of innovative control products each year that focus on a user-centric approach to building control products and applications that simplify user interaction with highly complex technologies in the home, removing interoperability challenges as a roadblock for user adoption, with a privacy-first and secure-by-design approach to today’s smart devices. www.uei.com

About Eneco: Eneco is an international energy company committed to accelerating the energy transition. Our One Planet Plan forms the basis for our ambition to become climate-neutral, in terms of both our own and our customers’ energy consumption. To this end, we focus on three actions: decarbonise our customers, generate more sustainable energy and balance and optimise the energy system. We invest in sustainable means of production, energy storage possibilities and smart energy solutions for consumers and businesses. Together we work on everyone’s sustainable energy. www.eneco.com

For more information, please contact:

Universal Electronics Inc.

Hrag G. Ohannessian, Senior Vice President of Global Sales, +1-626-840-0280 [email protected]

KEYWORDS: Arizona Europe United States Netherlands North America

INDUSTRY KEYWORDS: Consumer Electronics Technology Environment Utilities Green Technology Energy

MEDIA:

Photo
Photo
Universal Electronics and Eneco have partnered to launch the TIDE Touch, a next-generation smart thermostat. The device features built-in temperature, humidity, and proximity sensors that optimize energy use and home comfort.
Logo
Logo

Alpha and Omega Semiconductor’s New αMOSE2™ 600V Super Junction MOSFETs Support OptimizedElectrical/Thermal Paths, Boosted System Performance and Long-Term Reliability

Alpha and Omega Semiconductor’s New αMOSE2 600V Super Junction MOSFETs Support OptimizedElectrical/Thermal Paths, Boosted System Performance and Long-Term Reliability

Advanced AOGT037V60DE2 and AOGT060V60DE2 top-side cooled high-voltage MOSFETs deliver the power density and robustness required by high-performance power systems and solar inverters

SUNNYVALE, Calif.–(BUSINESS WIRE)–Alpha and Omega Semiconductor Limited (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices, wide-bandgap power devices, power management ICs and modules, today announced the release of αMOS E2™ 600V Super Junction MOSFETs: AOGT037V60DE2 and AOGT060V60DE2. AOS engineered its newly developed αMOS E2 High-Voltage MOSFET platform to meet the growing demands for enhanced efficiency and increased power density management capabilities. These 600V Super Junction MOSFETs provide excellent performance across a wide range of today’s higher voltage applications, including servers, workstations, telecom rectifiers, solar inverters, motor drives and industrial power systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908417289/en/

Advanced AOGT037V60DE2 and AOGT060V60DE2 top-side cooled high-voltage MOSFETs deliver the power density and robustness required by high-performance power systems and solar inverters.

Advanced AOGT037V60DE2 and AOGT060V60DE2 top-side cooled high-voltage MOSFETs deliver the power density and robustness required by high-performance power systems and solar inverters.

Users of the latest high-performance SMPS and solar inverters expect higher efficiency, greater power density, lower system cost and uncompromising robustness. The advanced technology features in AOS’ top-side-cooled high-voltage Super Junction MOSFETs address these needs. These devices also meet the critical requirements in multiple topologies such as boost PFC, totem-pole PFC (slow leg), LLC resonant, PSFB and cyclo-converters.

AOS’ αMOS E2 High-Voltage Super Junction MOSFET platform features exceptional body-diode ruggedness (di/dt = 1500 A/µs), superior avalanche (UIS) capability, and short-circuit withstand time (SCWT). This enhanced ruggedness translates into higher system-level reliability, helping to ensure robust operation even under abnormal scenarios. Furthermore, AOS combines this αMOS E2 silicon with its top-side-cooled GTPAK™ package to maximize thermal performance via the top-side cooling pad. As a result, system designers can fully optimize thermal dissipation and reclaim PCB space to maximize overall power density. By co-optimizing both the electrical and thermal paths, system performance and long-term reliability are greatly enhanced.

“Our top-side cooled GTPAK products, such as the AOGT037V60DE2 and AOGT060V60DE2, are engineered to meet the demands of high-performance AC/DC power supplies, DC/DC converters and DC/AC solar inverters. Electromagnetic emission (EMI) and density bottlenecks of traditional bottom-side cooling have been a major engineering hurdle. Our αMOSE2 top-side cooled solutions give designers a premier solution for mid-to-high-power systems, empowering the performance-driven power infrastructure, power supply units, and renewable energy systems,” said Simon Yu, Senior Manager of HV Product Line at AOS.

Technical Highlights

  • Top-Side Cooled Package maximizes power density by co-optimizing both the electrical and thermal paths.
  • Gull-Wing Leads deliver superior board-level reliability in mission-critical environments.
  • Robust built-in fast body diode reduces Qrr for high-stress applications
  • Enhanced robustness with strong UIS, inrush current handling, and wide SOA capabilities
  • Designed to prevent self-turn-on, ensuring reliable operation under dynamic conditions
  • Suitable for Boost PFC, Totem Pole PFC, LLC, PSFB, and CrCM H-4/Cyclo Inverter applications

Pricing and Availability

The AOGT037V60DE2 (600 V, 37 mΩ) and AOGT060V60DE2 (600 V, 60 mΩ) in top-side-cooled GTPAK packages are now available in production quantities with a lead time of 16 weeks. The unit prices for 1,000-piece quantities are $6.00 and $3.00, respectively.

About AOS

Alpha and Omega Semiconductor Limited, or AOS, is a designer, developer, and global supplier of a broad range of discrete power devices, wide bandgap power devices, power management ICs, and modules, including a wide portfolio of Power MOSFET, SiC, GaN, IGBT, IPM, TVS, HV Gate Drivers, Power IC, and Digital Power products. AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables us to introduce innovative products to address the increasingly complex power requirements of advanced electronics. AOS differentiates itself by integrating its Discrete and IC semiconductor process technology, product design, and advanced packaging know-how to develop high-performance power management solutions. AOS’ portfolio of products targets high-volume applications, including personal computers, graphics cards, data centers, AI servers, smartphones, consumer and industrial motor controls, TVs, lighting, automotive electronics, and power supply units for various equipment. For more information, please visit www.aosmd.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts, and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, references to the efficiency and capability of new products and the potential to expand into new markets. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include but are not limited to, the actual product performance in volume production, the quality and reliability of the product, our ability to achieve design wins, the general business and economic conditions, the state of the semiconductor industry, and other risks as described in the Company’s annual report and other filings with the U.S. Securities and Exchange Commission. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date unless otherwise stated, and AOS undertakes no duty to update such information except as required under applicable law.

Media Contact: Mina Galvan

Tel: 408.830.9742

Email: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Semiconductor Hardware Manufacturing Technology Engineering

MEDIA:

Photo
Photo
Advanced AOGT037V60DE2 and AOGT060V60DE2 top-side cooled high-voltage MOSFETs deliver the power density and robustness required by high-performance power systems and solar inverters.
Logo
Logo

Himax Unveils Industry-Leading eDP TDDI, Advancing Automotive Display Technology

Single-Chip Solution Integrates High-Speed eDP Interface, Touch, and Display Driver For Large-Format, High-Resolution Smart Car Displays

TAINAN, Taiwan, Sept. 08, 2026 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or the “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the unveiling of the industry-leading automotive TDDI (Touch and Display Driver Integration) with high-speed eDP interface support, the HX83196/HX83197 series. The new solution integrates a high-speed eDP interface, touch, and display driver into a single chip, addressing the demands of next-generation smart car displays for large-format, high-resolution, high-quality displays and responsive touch performance.

Himax’s new eDP TDDI adopts the latest eSRE (eDP Stream Regeneration Engine) technology, integrating TDDI with eDP transmission and reception functions into a single chip. It can directly receive and transmit high-bandwidth eDP signals, enabling cascaded configuration. Customers can flexibly adopt either a single-chip or two-chip cascaded design, depending on panel size and resolution requirements. The HX83197 further incorporates Himax’s industry-leading local dimming technology into the TDDI, eliminating the need for an additional Tcon while enhancing contrast and detail in bright and dark areas, with improved cost efficiency. The newly introduced eDP TDDI is currently in the design-in stage with multiple panel makers and will be showcased at the upcoming SID Vehicle Displays and Interfaces Symposium in Detroit, U.S.

The new eDP TDDI features the following advanced capabilities:

  • Flexible Cascading for Large-Format, High-Resolution Displays: The automotive display system requires only one eDP output interface to cascade two eDP TDDIs. A single eDP TDDI supports displays up to 17 inches with 3K resolution, while a two-chip cascaded configuration supports displays up to 30 inches with 6K resolution
  • High-Resolution Touch Display with Smooth Visual Performance: Features 2,560 source channels and 1,280 touch channels, supporting 60Hz and 90Hz refresh rates, for large-format, high-resolution touch displays and smooth visual performance
  • High Integration for Simplified System Architecture and Improved Cost Efficiency: Integrating an eDP 1.2 interface eliminates the need for the eDP-to-OLDI bridge IC required in conventional automotive display architectures. For single-display applications, it also supports a Direct DP architecture, allowing the SoC to transmit eDP signals directly to the eDP TDDI over a single cable without an additional SerDes, further simplifying system architecture and reducing cost
  • Enhanced Data Transmission Efficiency and High-Quality Display: Integrates eDP 1.4 DSC (Display Stream Compression) technology to reduce the bit rate and power consumption associated with high-resolution image transmission, while helping mitigate electromagnetic interference (EMI). Support for HDR10+ enhances contrast and detail across bright and dark areas for more natural and refined image quality
  • ALS-on-Panel Architecture for Simplified Display Design: Supports an interface for an on-panel Ambient Light Sensor (ALS), allowing the ALS to be placed directly on the panel without occupying display bezel space, for a cleaner, more streamlined display design

“Himax has been deeply engaged in the automotive display IC market for nearly two decades, establishing a leading position across multiple technologies while building one of the industry’s most comprehensive automotive display IC portfolios. As the market trends toward larger, higher-resolution displays and increasingly diverse display configurations in smart car interiors, we continue to develop and introduce innovative technologies and products to give customers more options tailored to their needs. Our new eDP TDDI is one such example, supporting large-format, high-resolution automotive displays with advanced touch functionality while simplifying display design and reducing cost. Multiple customer projects are already underway,” said Ming-Cheng Chiu, Executive Vice President of Touch and Display Business Unit at Himax.

About Himax Technologies, Inc.

Himax Technologies, Inc. (NASDAQ: HIMX) is a leading global fabless semiconductor solution provider dedicated to display imaging processing technologies. The Company’s display driver ICs and timing controllers have been adopted at scale across multiple industries worldwide including TVs, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, among others. As the global market share leader in automotive display technology, the Company offers innovative and comprehensive automotive IC solutions, including traditional driver ICs, advanced in-cell Touch and Display Driver Integration (TDDI), local dimming timing controllers (Local Dimming Tcon), Large Touch and Display Driver Integration (LTDI) and OLED display technologies. Himax is also a pioneer in tinyML visual-AI and optical technology related fields. The Company’s industry-leading WiseEyeTM Ultralow Power AI Sensing technology which incorporates Himax proprietary ultralow power AI processor, always-on CMOS image sensor, and CNN-based AI algorithm has been widely deployed in consumer electronics and AIoT related applications. Himax optics technologies, such as diffractive wafer level optics, LCoS microdisplays and 3D sensing solutions, are critical for facilitating emerging AR/VR/metaverse technologies. Additionally, Himax designs and provides touch controllers, OLED ICs, LED ICs, EPD ICs, power management ICs, and CMOS image sensors for diverse display application coverage. Founded in 2001 and headquartered in Tainan, Taiwan, Himax currently employs around 2,200 people from three Taiwan-based offices in Tainan, Hsinchu and Taipei and country offices in China, Korea, and the US. Himax has 2,555 patents granted and 318 patents pending approval worldwide as of June 30, 2026.

http://www.himax.com.tw

Forward Looking Statements

Factors that could cause actual events or results to differ materially from those described include, but are not limited to, the effect of the Covid-19 pandemic on the Company’s business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortage in supply of key components; changes in environmental laws and regulations; changes in export license regulated by Export Administration Regulations (EAR); exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory and other risks described from time to time in the Company’s SEC filings, including those risks identified in the section entitled “Risk Factors” in its Form 20-F for the year ended December 31, 2025 filed with the SEC, as may be amended.

Himax Contacts:

Karen Tiao, Head of IR/PR

Himax Technologies, Inc.
Tel: +886-2-2370-3999
Fax: +886-2-2314-0877
Email: [email protected]
http://www.himax.com.tw

Mark Schwalenberg, Director

Investor Relations – US Representative

MZ North America
Tel: +1-312-261-6430
Email: [email protected]



Hang Feng Technology Innovation Co., Ltd. Announces First Half 2026 Financial Results

PR Newswire

HONG KONG, Sept. 8, 2026 /PRNewswire/ — Hang Feng Technology Innovation Co., Ltd. (“Hang Feng Technology Innovation” or the “Company”), a Nasdaq-listed company headquartered in Hong Kong, announced its financial results for the six months ended June 30, 2026 (the “Reporting Period”) as previously furnished to the U.S. Securities and Exchange Commission on a current report on Form 6-K on September 4, 2026. The Company continues to execute its long-term strategic transformation while maintaining a highly capitalized and resilient balance sheet.

Key Financial & Operational Highlights

  • Capital Resources & Balance Sheet: As of June 30, 2026, total assets were $8,215,946, including $6,606,369 in cash. Total shareholders’ equity remained at $8,015,004.
  • Financial Performance: Total revenue for the Reporting Period was $362,511 (compared to $1,327,707 in the first half of 2025). The Company reported a net loss of $553,033 and a comprehensive loss of $593,754 (compared to net income of $363,524 and comprehensive income of $330,221 in the first half 2025). The net loss was primarily attributable to a sharp decline in revenue from the management consulting business. The decrease in corporate management consulting services revenue was primarily due to the Company’s shift in its strategic focus, which resulted in a reduction in business development and marketing activities for its existing operations and a reallocation of resources toward the development of its RWA initiatives. In response to these adjustments, the Company has been actively exploring new market opportunities to realign its operations with the evolving environment.
  • Interest Income Cushion: The Company recorded $329,755 in loan interest revenue during the Reporting Period, delivering a source of cash flow as core operations undergo realignment.

Strategic Corporate Development & Operational Updates

  1. Incorporation of Singapore Subsidiary: In May 2026, the Company incorporated a wholly‑owned subsidiary, HF Helios AI PTE Limited, in Singapore. The subsidiary was established to prepare for prospective cross‑border and tech‑driven business initiatives, and has not yet commenced operations.
  2. Capital Structure Reorganization: Following shareholder approval at the Extraordinary General Meeting on June 12, 2026, the Company completed a share capital re‑designation. The statutory capital structure was reorganized into 9,000,000,000 Class A Ordinary Shares and 1,000,000,000 Class B Ordinary Shares. As of June 30, 2026, 3,871,000 Class A Ordinary Shares and 4,000,000 Class B Ordinary Shares were issued and outstanding.
  3. Regulatory Licenses: Through its Hong Kong subsidiary, Hang Feng International Asset Management Limited (“HF IAM”), the Company held Type 4 (Advising on Securities) and Type 9 (Asset Management) regulated licenses issued by the Securities and Futures Commission (“SFC”) as of June 30, 2026. Subsequent to the Reporting Period, on July 7, 2026, HF IAM was granted a Type 1 (Dealing in Securities) license. The Company continues to advance its license portfolio to support diversified financial offerings.

Executive Commentary

XU Zhiheng, Chief Executive Officer of Hang Feng Technology Innovation, stated:

“The first half of 2026 was a period of proactive strategic reassessment for Hang Feng Technology Innovation. As highlighted in our financial report, our financial results reflect the shift in our strategic focus, leading to a planned reduction in business development and marketing activities for our traditional consulting sector as we reallocate resources toward our long-term RWA initiatives. Backed by a sound balance sheet with over $8 million in total assets and available liquid reserves, we believe we are well‑positioned to navigate near‑term uncertainties while remaining focused on long‑term value creation for our shareholders.”

About Hang Feng Technology Innovation Co., Ltd.

Hang Feng Technology Innovation Co., Ltd. is a Hong Kong‑based company providing comprehensive corporate management consulting solutions alongside specialized asset management services tailored to diverse client needs. Since 2023, Hang Feng has been offering consulting services through Starchain Investment Trading Limited (“Starchain”), one of its wholly‑owned subsidiaries, to a growing network of clients. Starchain delivers tailored management consulting, including strategic growth insights, performance management reporting, key performance indicator (KPI) advisory, and support in regulatory compliance, risk management, and corporate governance practices. In 2024, Hang Feng launched asset management services through its wholly‑owned subsidiaries, introducing structured solutions designed to manage and grow both corporate and individual capital portfolios. For more information, please visit Hang Feng’s IR website: https://ir.hfintech.io.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify many (but not all) of these statements by the use of words such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue,” or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will prove correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Investors are encouraged to review other factors that may affect the Company’s future results in the Company’s registration statement and other filings with the SEC.

Media & Investor Relations Contact

Hang Feng Technology Innovation Co., Ltd.
Email: [email protected]
Website: ir.hfintech.io

Cision View original content:https://www.prnewswire.com/news-releases/hang-feng-technology-innovation-co-ltd-announces-first-half-2026-financial-results-302872026.html

SOURCE Hang Feng Technology Innovation Co., Ltd.

IsoEnergy Completes Summer Drilling at Larocque East, Intersecting Widespread and Strongest Radioactivity to Date Along the Hurricane South Trend

PR Newswire

TORONTO, September 8, 2026 /PRNewswire/ — IsoEnergy Ltd. (“IsoEnergy”, or the “Company”) (NYSE American: ISOU); (TSX: ISO) is pleased to report on radioactive zones intersected in summer drilling along the Hurricane South Trend on the Larocque East project (the “Project“), which hosts the high-grade Hurricane deposit (“Hurricane” or the “Deposit“). Summer drilling at Larocque East totaled 10,159 m in 26 holes, for a year-to-date total of 16,963 m in 43 drill holes (Figure 1). The summer program was expanded from a planned 8,000 m, 20-hole program to follow up on encouraging winter and early summer results (see news release dated July 8, 2026). Highlights of drill core radiometric results and uranium geochemistry from the winter holes were reported on April 7, 2026 and May 12, 2026, respectively. All samples from the summer program have been submitted to SRC Geoanalytical Laboratories and results will be reported when available.

Hurricane hosts a current Mineral Resource of 48.6 Mlb U3O8 at 34.5% U3O8 Indicated, and 2.7 Mlb U3O8 at 2.2% U3O8 Inferred (see “Qualified Person Statement” below). The Project benefits from excellent infrastructure, located approximately 40 km northwest of the McClean Lake mill, and features relatively shallow mineralization at approximately 325 m depth, supporting efficient exploration and future development optionality. The Deposit is located on the Larocque Trend, an important regional structure that also hosts other notable high-grade occurrences including those on Cameco and Orano’s Dawn Lake joint venture.

Highlights

  • The summer drill program successfully intersected widespread, strongly elevated radioactivity over a strike length of 600 m along the South Trend.

    • 18 of the 26 holes returned intervals at or above the cut-off of >350 cps threshold over 0.5 m, 13 holes returned 1,000 cps or greater, and three holes returned over 35,000 cps including the strongest radioactivity drilled to date on the South Trend. All radioactivity results reported herein are measured on drill core as total counts per second (“cps”) with three readings averaged over each 0.5 m sample interval.
  • Drill holes LE26-250 and LE26-273 intersected strongly elevated radioactivity on the L fault zone along strike east and west of mineralization previously reported in winter drill hole LE26-248 (4.21% U

    3

    O

    8

    over 3.5 m, including up to 11.6% U

    3

    O

    8

    over 1.0 m).

    • LE26-250, drilled 75 m east of LE26-248 and outside the existing Hurricane footprint, intersected 11,075 cps over 3.5 m, including 43,160 cps over 0.5 m (see news release dated July 8, 2026).
    • LE26-273, drilled 11 m west of LE26-248, intersected 14,135 cps over 3.0 m, including 36,292 cps over 1.0 m. Like LE26-248, LE6-273 was drilled in the southernmost portion of the Deposit footprint in an area previously interpreted as within the low-grade shell. This interpretation will be revisited once uranium geochemistry results are available.  
  • Drill hole LE26-254 intersected strongly elevated radioactivity, on strike west of previously reported mineralization in winter drill hole LE26-234 (1.00% U

    3

    O

    8

    over 1.5 m, including up to 2.75% U

    3

    O

    8

    over 0.5 m), on the interpreted L fault zone 510 m east of the existing Hurricane footprint.

    • LE26-254, drilled 28 m west of LE26-234, intersected 10,110 cps over 2.0 m, including 35,900 cps over 0.5 m.

Table. 1 Selected Radioactivity Highlights, 2026 Summer Program, Larocque East Project1,2,3,4


Hole ID


Target Area


From (m)


To (m)


Length (m)


Radioactivity (cps)


LE26-250


West L Fault


341.0


344.5


3.5


11,075


Includes


342.0


342.5


0.5


43,160


LE26-254


East L Fault


331.5


333.5


2.0


10,110


Includes


333.0


333.5


0.5


35,900


LE26-273


West L Fault


328.0


331.0


3.0


14,135


Includes


328.5


329.5


1.0


36,292

1. See Table 2 for a listing of individual 0.5 m mineralized intervals defined as intervals over which average RS-125 handheld spectrometer readings on drill core exceeded 350 cps.

2. Radioactivity is total gamma from drill core measured with an RS-125 hand-held spectrometer.

3. Individual 0.5 m interval cps values reported throughout this press release are averages of three readings taken over the 0.5 m interval.

4. Measurements of total gamma cps on drill core are an indication of uranium content but may not correlate with uranium chemical assays.

Dan Brisbin, Vice President Exploration, commented, “Our Larocque project team and contractor partners safely completed an expanded summer program despite a temporary demobilization in June due to a nearby wildfire. Nearly half of the holes drilled in 2026 intersected elevated radioactivity. Multiple holes along the Hurricane South Trend returned strongly elevated results, including thirteen of the twenty-six summer holes at 1,000 cps or greater, both inside the Hurricane deposit footprint and along strike of it. Geochemical results are pending, and those assays, together with the geological observations from drill core, will shape how we define targets for 2027.”

Hurricane Resource Expansion Drilling

Summer drilling focused on expansion of the Hurricane mineral resource. Twenty-six holes were completed to target, with three holes abandoned in sandstone, for a total of 10,159 m. This was expanded from a planned 8,000 m in twenty holes based on early encouraging results. Aside from one hole (LE26-269) that tested the eastern extension of the Hurricane Main trend (Figure 1), all drilling was focused on the Hurricane South Trend. Within the South Trend, six holes tested J and K faults, and seventeen holes tested L fault. LE26-273 tested the L fault within the existing Deposit footprint and extended the zone of elevated radioactivity associated with mineralization intersected by winter hole LE26-248 (4.21% U3O8 over 3.5 m, including up to 11.6% U3O8 over 1.0 m) 11 m to the west.

The Hurricane area geological interpretation is being updated based on information gathered from the forty-three drill holes completed in 2026. Geochemical results will be added when received, and new and existing information integrated during evaluation of 2027 drill target potential.

Figure 1 – Map of the Larocque Trend on the Larocque East project showing the Hurricane deposit, drill hole unconformity intercept locations, and the interpreted traces of the H, I, J, K and L faults at the unconformity. The J, K and L faults, which comprise the Hurricane South Trend, were the focus of summer drilling. 2026 summer drill holes are colour-coded by radioactivity (cps) x core length (m) product (e.g. 1200 cps intersected along a 2 m core interval has a cps.m product of 2400). Previously released geochemical results for winter drill holes (see May 12, 2026 news release) are also shown. Unmineralized winter holes are labelled but not colour-coded for cps. 2025 and earlier drill holes are not labelled. Radiometric results for mineralized intervals in summer 2026 drill holes are provided in Table 2. *See Qualified Person Statement below.

The east-striking structures at Hurricane are grouped into three trends: the North Trend (not shown, minor unnamed faults north of the deposit), Main Trend (H and I faults), and the South Trend (J, K and L faults).

West L Fault Target

LE26-255, LE26-257, LE26-261, LE26-268, and LE26-270 to LE26-274 were drilled to follow up on strong radioactivity intersected in drill holes LE26-248 and LE26-250 on the L-fault zone. A strong illite spectral mineralogy signature dominates through the lower 150 m of sandstone with the lowermost five metres of sandstone dominantly characterized by a mix of illite and chlorite in most holes.

The West L fault target area was a major focus of the summer drill program. Many of the drill holes tested the optimal target position, specifically LE26-250, LE26-261, LE26-268, and LE26-273, where the results correlate with strongly elevated radioactivity. The Company is advancing a geological model for the area to assess its potential based on the winter and summer results.

LE26-250, drilled 75 m east of LE26-248, intersected 11,075 cps over 3.5 m, including 43,160 cps over 0.5 m (see news release dated July 8, 2026). This hole was drilled outside of the existing Hurricane footprint.

LE26-253 intersected elevated radioactivity averaging 620 cps over 0.5 m between 337.5 and 338.0 m, about 3 m above the unconformity (see news release dated July 8, 2026).  The sandstone column is dominantly illitic.

LE26-255 was drilled 30 m east of LE26-250 to test for mineralization The sandstone below 130 m is strongly illitic, transitioning to a mixture of chlorite and illite within 5.0 m of the unconformity. The sandstone is strongly altered with clay and limonite centred on fault zones 70 m above the unconformity. A 0.5 m graphitic fault was intersected 20.0 m below the unconformity.

LE26-257 was completed to test mineralization between LE26-243 and LE22-115A. It intersected an average of 686 cps from 326.5 to 331.0 m, including 1,960 cps and 1,225 cps over 0.5 m intervals. The sandstone column is dominantly illitic below 100 m. Limonite, chlorite, and secondary hematite alteration are associated with the mineralized interval.

LE26-261 intersected 1,094 cps over 3.0 m from 331.0 to 334.0 m. The sandstone column is dominantly illitic starting 215 m above the unconformity.

LE26-268 intersected 1,115 cps over 1.0 m from 329.5 to 330.5 m. The sandstone is dominantly illitic, apart from a 35 m interval in the lower sandstone.

LE26-270 intersected 870 cps over 1.0 m from 327.5 to 328.5 m. The sandstone column is dominantly illitic throughout, with the basal 2.0 m consisting of a mixture of illite, chlorite, and sudoite.

LE26-271 didn’t intersect elevated radioactivity, but significant alteration and structure were intersected starting 100 m above the unconformity. Fault-controlled hydrothermal hematite was intersected at 287 m and 302 m. Spectral clay analysis shows strong illite starting 200 m above the unconformity.

LE26-271C1 intersected 498 cps over 1.0 m from 330.0 to 331.0 m. The sandstone is dominantly illitic with mix of illite and chlorite from 5 m above the unconformity

LE26-272 intersected elevated radioactivity over 3.0 m from 322.5 to 327.0 m, featuring a maximum of 1,893 cps over 0.5 m. Illite dominated sandstone starts 200 m above the unconformity.

LE26-273 intersected elevated radiometry from 328.0 to 331.0 m, averaging 14,135 cps, including 36,292 cps over a 1.0 m interval.

LE26-274 intersected elevated radioactivity from 330.0 to 333.0 m, with a peak reading of 1,190 cps over a 0.5 m interval.

J and K Fault Targets

Drillholes LE26-251, LE26-258, LE26-259, LE26-260, LE26-265B, and LE26-267 targeted interpreted J fault at the unconformity.

LE26-251 was drilled to test the J fault at the unconformity (see news release dated July 8, 2026).  The sandstone column is illitic starting 180 m above the unconformity. The lower sandstone is moderately bleached, with frequent desilicified and argillized intervals centered on structure. Elevated radioactivity up to 1,580 cps was intersected over 0.5 m from 331.5 m to 332.0 m within an interval with strong sooty pyrite alteration, and within a broader interval straddling the unconformity which averages 980 cps over 3.0 m from 331.0 m to 334.0 m. The hole intersected the unconformity 6 m north of optimal target. LE26-258 was drilled to test the K fault at the unconformity. The hole intersected a strongly graphitic and pyritic unit that hosts multiple faults. The unconformity intercept in this hole is interpreted to be 10 metres south of the optimal target.

LE26-259 was drilled to test the K fault at the unconformity. The hole did not intersect elevated radioactivity.  A strongly graphitic fault is present 26 m below unconformity. The drill hole is interpreted to be 4 m north of the optimal target.

LE26-260 was drilled to test J fault at the unconformity. The hole intersected 1,971 cps over 4.5 m from 330.0 to 334.5 m, including 6,430 cps over 0.5 m. The sandstone column is illitic starting 200 m above the unconformity. The lower sandstone is strongly bleached, with frequent desilicified and argillized intervals centred on structure. Basement core includes strongly graphitic intervals and multiple graphitic faults. The hole tested optimal target.

LE26-265B was drilled to test J fault at the unconformity. The hole intersected strong alteration and structure in the basal sandstone and basement; however, no significant radioactivity was intersected. The drill hole is interpreted to 6 m north of the optimal target.

LE26-267 was drilled to test K fault at the unconformity. The hole didn’t intersect significant radioactivity. Moderate bleaching and interstitial clay were intersected through the lower sandstone. The drill hole intersected moderately illitic sandstones from 150 m to 15 m above the unconformity.  The basal 10 m of sandstone is a mix of chlorite and illite.  Basement core hosts multiple graphitic faults and the most significant is a 30 cm graphitic fault, intersected 13 m below the unconformity. The drill hole is interpreted to be 5 m north of the optimal target.

Central L Fault Target

Drill holes LE26-256 and LE26-263 were completed to extend mineralization intersected in LE21-101 and LE25-207. LE26-256 intersected an average of 633 cps over 2 m. A 16 m wide zone of broken core with moderate alteration was intersected 25.8 m above the unconformity, including strong hydrothermal hematite over a 2 m interval at 294 m. Basement core intersected a metre-scale cataclastic fault 39 m below the unconformity. This basement fault was targeted with drill hole LE26-263, which intersected 2,023 cps over 1.0 m from 322.5 to 323.5 m. The middle and basal sandstone is dominantly illitic in both drillholes. A significantly altered fault zone consisting of clay, limonite, and desilicification was intersected 19 m above the unconformity in drill hole LE26-263. Sooty pyrite and chloritization are associated with the mineralized zone, and basement core is strongly chloritized down to 10 m below the unconformity. Potential remains open along east for 150 m.

Hurricane Main Trend Target

LE26-269 was drilled on the Hurricane Main Trend 40 m east of the existing Deposit footprint. It intersected a maximum of 476 cps over a 0.5 m sample. The sandstone column 170 m above the unconformity is strongly illitic, while the basal 5 m above the unconformity contains a mixture of chlorite and kaolinite.

Southeast L Fault Target

Drill holes LE26-252, LE26-254, LE26-262, LE26-264, LE26-266A were completed on the eastern portion of interpreted L-fault. 

LE26-252 was drilled 30 m east of mineralized winter hole LE26-234 (see news release dated July 8, 2026). The sandstone is moderately bleached below 143.5 m. Multiple fault zones with strong quartz dissolution and white clay were intersected through lower sandstone. The basement rocks are moderately to strongly clay altered to 337.7 m, with weakly elevated radioactivity intersected within the clay altered zone (450 cps over 0.5 m from 333.5 m to 334.0 m). The drill hole is interpreted to be 8 m north of the optimal target.

LE26-254 was drilled 27 m west of mineralized drill hole LE26-234. It intersected elevated radioactivity immediately below the unconformity from 331.5 to 333.5 m averaging 10,110 cps, including 35,900 cps over 0.5 m. The lower sandstone unit is strongly altered, with bleaching, argillization, and desilicification centered on fault zones, alongside patches of hydrothermal hematite immediately above the mineralized zone. The sandstone column below 140 m has a dominantly illitic signature. Basement core down to 40 m below the unconformity is moderately altered with pervasive, mineral-controlled clay and chloritization. Radioactivity was intersected in the basement rather than at the unconformity, but the drill hole is interpreted to have tested the optimal target position, with the basement structure intersected immediately below the unconformity.

LE26-262 was drilled up-dip of a basement structure intersected in drill hole LE26-252. It intersected strong alteration consisting of bleaching, desilicification, and argillization roughly 100 m above the unconformity. The basal sandstone includes secondary hematitization centred on a fault and strong clay replacement. The hole is interpreted to have intersected the unconformity 12 m south of the optimal target.

LE26-264 was drilled to test the L fault at the unconformity between LE26-234 and LE26-254. The hole intersected 849 cps over 5.0 m from 324.0 to 329.0 m, including 2,490 cps over 1.0 m from 326.5 to 327.5 m. Middle and basal sandstone is dominantly illitic. Strongly bleached core begins 50 m above the unconformity, featuring patches of limonite and argillized intervals. A secondary radioactive interval in the basement (610 cps at 334.5 m) is associated with secondary hematite and clay. The hole achieved its objective, intersecting elevated radioactivity at the unconformity.

LE26-266A was planned as step-out hole approximately 140 m east of mineralization intersected in previous holes to test the extent of the alteration footprint in the eastern part of the L-fault. It intersected strongly bleached, argillized, and limonitized alteration centred on a fault zone over an 80.0 m wide interval above the unconformity. The unconformity intercept is 20 m south of the interpreted optimal target and potential along strike remains open.

Table 2. Summer 2026 drill hole summary and RS-125 spectrometer results on intervals in which radioactivity exceeded 350 cps averaged over 0.5 m measured on core. 

Table 2 footnote - LE26-265, LE26-265A, and LE26-266 were abandoned in sandstone and not listed. LE26-271C1 is a wedge off LE26-271. Both were completed to target and so both are listed.

Table 2.

Table 2.

Qualified Person Statement

The scientific and technical information contained in this news release was reviewed and approved by Dr. Dan Brisbin, P.Geo., IsoEnergy’s Vice President, Exploration, who is a “Qualified Person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects). See the April 7, 2026 press release for information on quality assurance/quality control procedures. Dr. Brisbin has verified the data disclosed herein. Data verification procedures included comparing radioactivity measured on core with the RS-125 spectrometer to radioactivity measured downhole with the 2PGA probe, comparing RS-125 data to cps values marked on core boxes in core photos, and checking reported composite lengths and cps values. For additional information regarding the Company’s Larocque East Project, including the current mineral resource estimate for IsoEnergy’s Hurricane Deposit, please see the technical report entitled “Technical Report on the Larocque East Project, Northern Saskatchewan, Canada” dated August 4, 2022, available on the Company’s profile at www.sedarplus.ca.

About IsoEnergy Ltd.

IsoEnergy (NYSE American: ISOU; TSX: ISO) is a leading, globally diversified uranium company with substantial current and historical mineral resources in top uranium mining jurisdictions of Canada, the U.S. and Australia at varying stages of development, providing near-, medium- and long-term leverage to rising uranium prices. IsoEnergy is currently advancing its Larocque East project in Canada’s Athabasca basin, which is home to the Hurricane deposit, boasting the world’s highest-grade indicated uranium mineral resource.

X: @IsoEnergyLtd www.isoenergy.ca

Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation (collectively, referred to as “forward-looking information”). Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These forward-looking statements or information may relate to statements with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, including, without limitation, the anticipated results from the 2026 exploration activities and expected timing for reporting thereof. Generally, but not always, forward-looking information and statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof.

Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management at the time, are inherently subject to business, market and economic risks, uncertainties
and
contingencies
that
may
cause
actual
results,
performance
or
achievements
to
be
materially different from those expressed or implied by forward-looking statements. Such assumptions include, but are not
limited
to,
assumptions
that
the
results
of
planned
exploration
activities
are
as
anticipated;
the
anticipated mineralization
of
IsoEnergy’s
projects
being
consistent
with
expectations
and
the
potential
benefits
from
such projects and any upside from such projects; the price of uranium; that general business and economic conditions
will
not
change
in
a
materially
adverse
manner;
that
financing
will
be
available
if
and
when
needed and on reasonable terms; that third party contractors, equipment and supplies and governmental and other approvals required to conduct the Company’s planned activities will be available on reasonable terms and in a timely manner. Although IsoEnergy has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking
information.

Such statements represent the current views of IsoEnergy with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by IsoEnergy, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Risks and uncertainties include, but are not limited to the following: negative operating cash flow
and
dependence
on
third
party
financing;
uncertainty
of
additional
financing;
no
known
mineral
reserves; aboriginal title and consultation issues; reliance on key management and other personnel; actual results of exploration activities being different than anticipated; changes in exploration programs based upon results; availability of third party contractors; availability of equipment and supplies; failure of equipment to operate as anticipated; accidents, effects of weather and other natural phenomena; other environmental risks; changes in laws and regulations; regulatory determinations and delays; stock market conditions generally; demand, supply and pricing for uranium; other risks associated with the mineral exploration industry, and general economic and political conditions in Canada, the United States and other jurisdictions where the Company
conducts
business.
Other
factors
which
could
materially
affect
such
forward-looking
information
are described in the risk factors in IsoEnergy’s most recent annual management’s discussion and analysis and annual
information
form
and
IsoEnergy’s
other
filings
with
the
securities
regulators
which
are
available
under the Company’s profile on SEDAR+ at

www.sedarplus.ca

and and on EDGAR at

www.sec.gov.

IsoEnergy does not undertake to update any forward-looking information, except in accordance with applicable securities
laws.


Cautionary Note to United States Investors Regarding Presentation of Mineral Resource Estimates

The mineral resource estimates included in this press release have been prepared in accordance with the requirements of the securities laws in effect in Canada and Australia, as applicable, which differ in certain material respects from the disclosure requirements promulgated by the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, information contained in this press release may not be comparable to similar information made public by U.S. companies reporting pursuant to SEC disclosure requirements.

IsoEnergy Ltd.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/isoenergy-completes-summer-drilling-at-larocque-east-intersecting-widespread-and-strongest-radioactivity-to-date-along-the-hurricane-south-trend-302871790.html

SOURCE IsoEnergy Ltd.

CIOs Carry the Blame for AI Failure, Often Without the Authority to Prevent It, 8×8 Survey Finds

CIOs Carry the Blame for AI Failure, Often Without the Authority to Prevent It, 8×8 Survey Finds

Technology leaders worldwide are struggling with an accountability gap between AI adoption and governance infrastructure

CAMPBELL, Calif.–(BUSINESS WIRE)–A majority of technology leaders, 52%, say they hold the CIO accountable when an AI agent makes an error. In fact, CIOs shoulder the blame far more often than any other function, including legal, compliance, and customer service.

That’s a topline finding of Communications Reckoning: When the AI Agent Fails, Someone Has to Answer, a global survey commissioned by 8×8, Inc. (NASDAQ: EGHT), a leading global business communications platform provider. In July 2026, 8×8 commissioned independent research through Censuswide, surveying 2,501 CIOs and CTOs across the UK, USA, France, Australia, and the Republic of Ireland to ask them what AI disruption looks like from the front lines.

“The CIO is now the last line of defense for AI, and in a lot of organizations, that’s a job they didn’t apply for,” said Samuel Wilson, Chief Executive Officer at 8×8, Inc. “The CIO didn’t choose the vendor and they don’t always have the audit trail. But when an AI agent gets it wrong, their name is the one in the incident report. That’s not sustainable, and it’s not how you build a governance model that holds up under scrutiny. The fix isn’t more oversight. It’s giving the people with the accountability the visibility to match it. ”

Fair or not, the CIO owns AI risk

Accountability for AI behavior across the business has landed on one desk, the CIO’s, and it has often happened without a matching increase in governance tools or authority. 52% of those surveyed said the CIO is on the hook when an AI agent makes an error, compared with just 16% for customer service leadership and 6% for legal or compliance teams.

Data sovereignty is now a board-level concern

The survey shows that 82% of responding CIOs say AI infrastructure location matters, with 30% calling it the primary factor in vendor decisions, and 52% describing it as one of several critical considerations. This reinforces data released last month showing 89% of technology leaders say data sovereignty has climbed their list of priorities over the past 12 months, reflecting mounting regulatory pressure tied to GDPR, HIPAA, CCPA, and similar regulations.

“While many think it’s only Europeans worrying about data sovereignty, the data shows that it’s a huge issue in the US as well,” said Wilson. “This reflects that when you are dealing with data jumping over borders and where infrastructure is located across multiple vendors and tech stacks, it’s really a problem for everyone.”

Consolidation has stalled, but not for lack of capable technology

When asked about streamlining vendors and their technology stack, only 9% of CIOs say no single platform can meet their organization’s requirements, a signal that the market has the technical capability to solve fragmentation. The largest obstacles were cited as being:

  • 30% said migration cost and complexity
  • 24% said regulatory or data residency constraints
  • 16% said vendor lock-in
  • 15% said internal politics and stakeholder alignment across teams

“The encouraging part of this research is that the technology to fix this fragmentation already exists,” Wilson added. “What’s missing is a partner willing to help organizations navigate the politics and the change management, not just sell them another platform. That’s the harder job, and for a partner willing to step up, there are rewards to be had.”

Governance is the biggest gap

Communications infrastructure is no longer only the supporting layer for AI. For most organizations, it has become the governance layer, the place where accountability, data control, and vendor sprawl all converge.

“CIOs aren’t short on technology options,” said Wilson. “They’re short on one view across everything they’ve already bought. Closing that gap is what will separate the organizations that get ahead with AI from the ones that just get exposed by it.”

The report, ‘Communications Reckoning: AI Complexity and the Multi-Vendor Data Problem,’ is available for download at https://www.8×8.com/communications-reckoning/when-ai-fails.

This is the first of a three-part Communications Reckoning series that will continue throughout 2026 and 2027.

About 8×8, Inc.

8×8, Inc. (NASDAQ: EGHT) connects people and organizations through seamless communication on one of the industry’s most integrated platforms for Customer Experience – combining Contact Center, Unified Communications, and CPaaS APIs. The 8×8® Platform for CX integrates AI to enable personalized customer journeys, drive operational excellence and insights, and facilitate team collaboration. As a business communications leader, the company helps customer experience and IT leaders around the world become the heartbeat of their organizations, empowering them to unlock the potential of every interaction. For additional information, visit www.8×8.com, or follow 8×8 on LinkedIn, X, and Facebook.

Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the expected impact of AI in the workplace and how businesses may respond. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed or implied. For a more complete description of these and other risk factors, please refer to 8×8’s filings with the Securities and Exchange Commission. 8×8 undertakes no obligation to update these statements to reflect events occurring after the date of this press release, except as required by law.

8×8, Inc. Contacts:
Media:
PR@8×8.com

Investor Relations:
Investor.Relations@8×8.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: VoIP Technology Telecommunications Artificial Intelligence Software

MEDIA:

Logo
Logo

EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc. Securities Fraud Lawsuit with SBS Law

PR Newswire

LOS ANGELES, Sept. 8, 2026 /PRNewswire/ — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against EquipmentShare.com Inc. (“EquipmentShare” or “the Company”) (NASDAQ: EQPT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of EQPT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: January 23, 2026 to June 23, 2026

DEADLINE: September 21, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. EquipmentShare engaged in related party transactions that it failed to disclose. The Company did not end or even substantially reduce the number of transactions it completed with entities owned by its cofounders. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about EquipmentShare, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

Cision View original content:https://www.prnewswire.com/news-releases/eqpt-investors-have-opportunity-to-lead-equipmentsharecom-inc-securities-fraud-lawsuit-with-sbs-law-302871817.html

SOURCE Schall, Brown & Schwartz LLP

CCOI Investors Have Opportunity to Lead Cogent Communications Holdings, Inc. Securities Fraud Lawsuit with SBS Law

PR Newswire

LOS ANGELES, Sept. 8, 2026 /PRNewswire/ — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cogent Communications Holdings, Inc. (“Cogent” or “the Company”) (NASDAQ: CCOI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of CCOI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 29, 2024 to May 1, 2026

DEADLINE: September 21, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Cogent’s backlog of supposed orders for its optical wavelength products were not likely to generate revenue. Customers in the Company’s backlog were unwilling to accept delivery even if it was capable of delivering its products and services. The Company was not on track to achieve revenue targets and other performance goals. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Cogent, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

Cision View original content:https://www.prnewswire.com/news-releases/ccoi-investors-have-opportunity-to-lead-cogent-communications-holdings-inc-securities-fraud-lawsuit-with-sbs-law-302871813.html

SOURCE Schall, Brown & Schwartz LLP

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

– Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma –

– Verekitug also delivered clinically meaningful improvements in lung function (FEV

1

) and exhaled nitric oxide (FeNO) with every 12-week dosing

– The Company remains on track to initiate Phase 3 trials in severe asthma and CRSwNP in
Q1 2027
, designed to deliver best-in-class efficacy in both indications by evaluating a 400 mg quarterly regimen of verekitug in broad patient populations –

WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for severe inflammatory respiratory diseases, today presented results from the Phase 2 VALIANT clinical trial evaluating the safety and efficacy of verekitug in adults with severe asthma in a late-breaking oral presentation at the European Respiratory Society (ERS) Congress 2026 in Barcelona. Verekitug is the only known antagonist currently in clinical development that targets and inhibits the thymic stromal lymphopoietin (TSLP) receptor.

As previously reported, VALIANT met the study’s primary endpoint of a statistically significant and clinically meaningful reduction in the annualized asthma exacerbation rate (AAER) across all dose regimens studied. Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% (p<0.001) compared to placebo. Statistically significant reductions in AAER were also observed in the two other dose arms.

“We are excited to share results of the Phase 2 VALIANT study, which demonstrate that treatment with verekitug led to significant and substantial improvements in asthma exacerbations, lung function and inflammatory biomarkers, at this year’s ERS Congress,” said Aaron Deykin, MD, Chief Medical Officer and Head of Research & Development at Upstream Bio. “The compelling efficacy profile, highlighted by a 56% reduction in AAER observed in patients receiving verekitug every 12 weeks, together with the favorable safety results, reinforces the potential of targeting the TSLP receptor to potently address key measures of disease. These findings, part of the dataset from more than 500 trial participants treated with verekitug to date, further strengthen our conviction in verekitug’s potential to deliver best-in-class efficacy with the convenience of quarterly dosing, a profile we plan to further evaluate in a broad severe asthma population in Phase 3.”

“Despite the availability of effective biologic therapies, there continues to be a need for treatments that can provide meaningful disease control while reducing patient burden,” said Michael Wechsler, MD, MMSc, Professor of Medicine, Director of National Jewish Cohen Family Asthma Institute and principal investigator on the VALIANT trial. “The consistency and magnitude of improvement observed with verekitug in the VALIANT study suggests it has the potential to deliver meaningful clinical benefit for people living with severe asthma. The substantial reduction in asthma exacerbations, together with improvements across multiple measures of disease activity including lung function, demonstrate verekitug’s potential to achieve strong disease control with infrequent dosing. These results support its continued development as an important potential treatment option for severe asthma.”

VALIANT (NCT06196879) is a Phase 2 global, randomized, double-blind, placebo-controlled, dose-ranging, parallel group clinical trial that evaluated the safety and efficacy of verekitug in 478 patients with severe asthma. Patients were enrolled regardless of baseline blood eosinophil count or other type-2 biomarker levels. The trial was designed with a variable treatment period with all participants having at least 24 weeks of treatment and those enrolled prior to the last randomized participant having additional treatment up to a maximum of 60 weeks.

Verekitug improved the key secondary outcomes of FEV1 (forced expiratory volume in one second), FeNO (fractional exhaled nitric oxide), and asthma symptom control as measured by Asthma Control Questionnaire (ACQ-6) versus placebo at week 24, with improvements seen as early as week 2 across all key secondary outcomes.

Verekitug was generally well tolerated across all active doses, demonstrating a favorable safety profile consistent with previous studies. Immunogenicity had no meaningful impact on safety or efficacy results.

Eligible participants who completed the Phase 2 VALIANT clinical trial were offered enrollment in VALOUR (NCT06966479), a long-term extension (LTE) study designed to evaluate the long-term safety and efficacy of verekitug. VALOUR completed enrollment in March 2026 with more than 90% retention of eligible patients from the Phase 2 VALIANT study, with data expected in the second half of 2027.

As previously announced, Upstream Bio remains on track to initiate Phase 3 clinical trials with verekitug administered every 12 weeks in severe asthma and CRSwNP in the first quarter of 2027. The Phase 3 trials will evaluate 400 mg of verekitug administered every 12 weeks, versus placebo, with the goal to deliver best-in-class efficacy with quarterly at-home administration for patients with severe asthma and CRSwNP, in broad study populations without restriction based on baseline biomarkers.

A digital version of the presentation and e-poster can be found on the Publications section of the Upstream Bio website.

About Verekitug

Verekitug is a novel recombinant fully human immunoglobulin G1 (IgG1) monoclonal antibody that binds to the thymic stromal lymphopoietin (TSLP) receptor and inhibits proinflammatory signaling initiated by TSLP. It is the only known antagonist currently in clinical development that targets and inhibits the TSLP receptor.

TSLP is a cytokine that is a key driver of the inflammatory response in major allergic and inflammatory diseases, such as asthma, where disruption of TSLP signaling has been clinically validated as an effective therapeutic strategy. TSLP activation is one of the first events in the inflammatory cascade stimulated by allergens, viruses and other triggers, initiating the activation of downstream targets such as IL-4, IL-5, IL-13, IL-17 and IgE. Because TSLP is a target upstream in the inflammatory cascade, blocking the TSLP receptor presents an opportunity for a single treatment to impact the drivers of multiple pathological inflammatory processes across a broad set of diseases.

With more than 500 participants treated with verekitug across its clinical development programs and positive Phase 2 results in severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), verekitug has a substantial body of clinical evidence supporting its advancement into Phase 3 development in both diseases. Verekitug is also being evaluated in an ongoing Phase 2 trial in chronic obstructive pulmonary disease (COPD).

About Upstream Bio

Upstream Bio is a clinical-stage biotechnology company developing treatments for severe inflammatory respiratory diseases. The Company is developing verekitug, the only known antagonist currently in clinical development that targets and inhibits the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple inflammatory pathways. With more than 500 participants treated with verekitug across its clinical development programs and positive Phase 2 results in chronic rhinosinusitis with nasal polyps (CRSwNP) and severe asthma, verekitug has a substantial body of clinical evidence supporting its advancement into Phase 3 development in both diseases. Verekitug is also being evaluated in an ongoing Phase 2 trial in chronic obstructive pulmonary disease (COPD). Upstream Bio is focused on leveraging verekitug’s differentiated mechanism, potency, and potential for extended dosing to develop a treatment which may deliver best-in-class efficacy and quarterly dosing for patients underserved by today’s standard of care.

To learn more, please visit www.upstreambio.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “continue,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “predict,” “project,” “seeks,” “should,” “target,” “will” and variations of these words or similar expressions. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, without limitation, express or implied statements regarding: the clinical development of verekitug for the treatment of severe asthma, CRSwNP and COPD, including the Company’s plans to initiate Phase 3 clinical trials in severe asthma and CRSwNP in the first quarter of 2027 and the timing, progress and results of ongoing and planned clinical trials; expectations regarding the potential of verekitug to deliver best-in-class efficacy and its differentiation, safety, and tolerability; and expectations regarding regulatory interactions with the U.S. Food and Drug Administration, including the Company’s Phase 3 clinical development plans in severe asthma and CRSwNP and the outcomes of any such interactions. Any forward-looking statements in this press release are based on the Company’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Readers are cautioned that actual results, levels of activity, safety, efficacy, performance or events and circumstances could differ materially from those expressed or implied in the Company’s forward-looking statements due to a variety of risks and uncertainties, which include, without limitation, risks and uncertainties related to: Upstream Bio’s ability to advance verekitug through clinical development, and to obtain regulatory approval of and ultimately commercialize verekitug on the expected timeline, if at all; the results of preclinical studies or clinical studies not being predictive of future results in connection with future studies; the initiation, timing, progress and results of clinical trials; Upstream Bio’s ability to fund its development activities and achieve development goals; Upstream Bio’s dependence on third parties to conduct clinical trials and manufacture verekitug, and commercialize verekitug, if approved; Upstream Bio’s ability to attract, hire and retain key personnel, and protect its intellectual property; Upstream Bio’s financial condition and need for substantial additional funds in order to complete development activities and commercialize verekitug, if approved; regulatory developments and approval processes of the U.S. Food and Drug Administration and comparable foreign regulatory authorities, including any additional interactions with the FDA regarding the sufficiency of Upstream Bio’s Phase 3 development plans; Upstream Bio’s competitors and industry; and other risks and uncertainties described in greater detail under the caption “Risk Factors” in Upstream Bio’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, as well as any subsequent filings with the SEC. Any forward-looking statements represent Upstream Bio’s views only as of today and should not be relied upon as representing its views as of any subsequent date. Upstream Bio explicitly disclaims any obligation or undertaking to update any forward-looking statements contained herein to reflect any change in its expectations or any changes in events, conditions or circumstances on which any such statement is based except to the extent required by law, and claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

Investor and Media Contact:

Meggan Buckwell
Senior Director, Corporate Communications and Investor Relations
[email protected]